logo

For the Inventor, By the Inventor

Seoul, South Korea

Kobiolabs, Inc.


USPTO Granted Patents = 13


Trademarks = 2

Forward Citations = 3

Loading Chart...
Loading Chart...

35 inventors (with patents filed for the assignee):

goldMedal Gwang Pyo Ko (10 out of 10 patents)

silverMedal Tae-Wook Nam (5 out of 5 patents)

bronzeMedal Hyun Ju You (5 out of 5 patents)

4.  Boram Seo (4 out of 4 patents)

5.  Woo Ri Ko (4 out of 4 patents)

6.  June Chul Lee (4 out of 6 patents)

7.  Woon Ki Kim (4 out of 4 patents)

8.  GwangPyo Ko (3 out of 4 patents)

9.  Tae Wook Nam (3 out of 4 patents)

10.  Jin-Woo Lee (2 out of 65 patents)

11.  Woonki Kim (2 out of 2 patents)

12.  You-Jin Jang (2 out of 2 patents)

13.  June-Chul Lee (2 out of 2 patents)

14.  Insu Kim (2 out of 2 patents)

15.  Dae Hee Han (2 out of 5 patents)


13 patents:

1. 12441979 - strain and use thereof (2025-10-14),
2. 12274718 - Composition and method for preventing, alleviating, or treating liver injury (2025-04-14),
3. 12070477 - sp. strain having ability to inhibit growth of vaginal pathogenic microorganisms (2024-08-27),
4. 11992511 - strain and use thereof (2024-05-28),
5. 11903980 - Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community (2024-02-20),
6. 11819526 - Lactobacillus Gasseri KBL697 strain and use thereof (2023-11-21),
7. 11633439 - Lactobacillus crispatus KBL693 strain and use thereof (2023-04-25),
8. 11602552 - Lactobacillus plantarum KBL396 strain and use thereof (2023-03-14),
9. 11510948 - Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community (2022-11-29),
10. 11365452 - Composition for diagnosing or predicting risk of metabolic syndrome or metabolic syndrome-related diseases using human oral microbiome (2022-06-21),
11. 11291698 - strain and use thereof (2022-04-05),
12. 11285183 - KBL697 strain and use thereof (2022-03-29),
13. 11141444 - KBL693 strain and use thereof (2021-10-12),
Company Overview
Kobiolabs, Inc. is a technology company based in Seoul, South Korea, specializing in innovative solutions within the fields of biotechnology and healthcare. The organization focuses on developing advanced medical devices and diagnostic tools aimed at enhancing patient care and improving health outcomes. With a commitment to research and development, Kobiolabs leverages cutting-edge technology to address critical challenges in the medical sector, positioning itself as a key player in the evolving landscape of healthcare innovation.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

13 Patents

#316 in Seoul

#874 in South Korea

#44,988 in the World

Seoul, KR
Seoul, South Korea

Kobiolabs, Inc.

Forward Citations = 3

35 inventors:

goldMedal Gwang Pyo Ko (10 out of 10 patents)

silverMedal Tae-Wook Nam (5 out of 5 patents)

bronzeMedal Hyun Ju You (5 out of 5 patents)

4.  Boram Seo (4 out of 4 patents)

5.  Woo Ri Ko (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kobiolabs, Inc.. Retrieved from https://idiyas.com/company/kobiolabs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…